This is the big question for many people: If I take a GLP-1 drug, am I increasing my risk of breast canceror other cancers? So far, based on large studies, meta-analyses, and case-controlled studies, the answer appears to be: No, GLP-1 agonists do not increase overall cancer risk or breast cancer risk
doi: 10.7759/cureus.50199 95 Wahab Al-ShabanSAHassan Al-BayatiAAShakerAAliKA-W
In certain cases particularly when response is limited or short-lived surgery may offer a more effective path forward
In the 1960s, Maibach and Kligman 16 analyzed sunless tanner with varying DHA concentrations as a treatment for vitiligo, finding that 5% DHA concentration was satisfactory for White patients, while up to 30% concentration was necessary for Black patients
Learn how you can maximize fat burning by pairing Energy Gel with L-Carnitine and Fusion
In fact, most nutritional research suggests the opposite